Philadelphia Positive Acute Lymphoblastic Leukemia

9 clinical trials · Condition

Record	Firm	Date
A Study of Dasatinib Plus Reduced Intensive Consolidation Chemotherapy in Ph+ Adult ALL (NCT05026229)	First Affiliated Hospital Xi'an Jiaotong University	2021-09-06
A Study of TKI Maintenance Therapy Following Allo-HSCT in Newly Diagnosed Ph+ Adult ALL (NCT05024357)	First Affiliated Hospital Xi'an Jiaotong University	2021-09-06
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL (NCT04260022)	Ascentage Pharma Group Inc.	2020-01-09
SCT in Ph Positive Acute Lymphoblastic Leukemia (NCT03821727)	CANDONI ANNA	2016-10-26
Phase I/II Study of Nilotinib/Ruxolitinb Therapy for TKI Resistant Ph-Leukemia (NCT01914484)	University Health Network, Toronto	2013-08-01
Study of Frontline Dasatinib Plus Chemotherapy in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (PH+ALL) (NCT01724879)	Goethe University	2011-11-01
Study Comparing Imatinib With Chemotherapy as Induction in Elderly Patients With Philadelphia Positive Acute Lymphoblastic Leukemia (ALL) (NCT00199186)	Johann Wolfgang Goethe University Hospital	2002-03-01

Every clearance here is in the API, with alerts when new ones post.